Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice.
Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice.
复制标题
JAK2V617F 转基因小鼠心脏肥大与骨髓增生性肿瘤相关
DOI:
10.1186/1756-8722-7-25
复制
发表时间:
2014-03-19
影响因子:
28.5
通讯作者:
Zhao ZJ
中科院分区:
文献类型:
--
作者:
Shi K;Zhao W;Chen Y;Ho WT;Yang P;Zhao ZJ
BackgroundMyeloproliferative neoplasms (MPNs) are blood malignancies manifested in increased production of red blood cells, white blood cells, and/or platelets. A major molecular lesion associated with the diseases is JAK2V617F, an activation mutation form of tyrosine kinase JAK2. Cardiovascular events represent the leading cause of morbidity and mortality associated MPNs, but the underlying mechanism is not well understood.MethodsPreviously, we generated JAK2V617F transgenic mice which displayed MPN-like phenotypes. In the present study, we further characterized these mice by analyzing the time course of MPN phenotype development and associated cardiac abnormalities. We performed detailed histochemical staining of cardiac sections.ResultsJAK2V617F transgenic mice developed cardiomegaly as a subsequent event of increased blood cell production during the course of MPN phenotype development. The cardiomegaly is manifested in increased ventricular wall thickness and enlarged cardiomyocytes. Trichrome and reticulin staining revealed extensive collagen fibrosis in the heart of JAK2V617F transgenic mice. Thrombosis in the coronary artery and inflammatory cell infiltration into cardiac muscle were also observed in JAK2V617F transgenic mice, and the latter event was accompanied by fibrosis.ConclusionJAK2V617F-induced blood disorders have a major impact on heart function and lead to cardiac hypertrophy. JAK2V617F transgenic mice represent an excellent model system to study both hematological malignancies and cardiovascular diseases.
登录
查看更多内容
影响因子:
28.5
作者:
Talpaz M;Paquette R;Afrin L;Hamburg SI;Prchal JT;Jamieson K;Terebelo HR;Ortega GL;Lyons RM;Tiu RV;Winton EF;Natrajan K;Odenike O;Claxton D;Peng W;O'Neill P;Erickson-Viitanen S;Leopold L;Sandor V;Levy RS;Kantarjian HM;Verstovsek S
通讯作者:
Verstovsek S
影响因子:
3.7
作者:
Jin X;Zhao W;Shi K;Ho WT;Zhao ZJ
通讯作者:
Zhao ZJ
影响因子:
20.3
作者:
Beer PA;Erber WN;Campbell PJ;Green AR
通讯作者:
Green AR
影响因子:
20.3
作者:
Tefferi, Ayalew;Thiele, Juergen;Vardiman, James W.
通讯作者:
Vardiman, James W.
影响因子:
20.3
作者:
Ogilvy, S;Elefanty, AG;Adams, JM
通讯作者:
Adams, JM